Vaxcyte Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 68.89, 173.05, 843.22, 2321.7 ], "ebit_estimate": [ -1078.74, -1128.76, -990.59, -239.53, 698.76 ], "ebitda_estimate": [ -1190.09, -972.43, -806.93, null, null ], "net_income_estimate": [ -1207.41, -1018.39, -1032.02, -186.03, 354.63 ], "per_share_eps_estimate": [ -8.5, -6.65, -7.04, -2.97, 2.46 ], "eps_nri_estimate": [ -8.38, -6.69, -6.56, -2.14, 2.46 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ -1223.06, -1034.14, -1051.63, -186.03, 960.8 ], "operating_cash_flow_per_share_estimate": [ -5.27, -4.55, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -42, null, null, null, null ], "gross_margin_estimate": [ null, 85, 88, 87.67, 88 ], "operating_cash_flow_estimate": [ -735.2, -634.76, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 23.68 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, null, null, null, null ], "ebit_estimate": [ -319.78, -325.23, -326.03, -246.47, -275.9, -275.9, -277.2 ], "ebitda_estimate": [ -273.97, -282.1, -273.84, -208.9, null, null, null ], "net_income_estimate": [ -298.28, -308.78, -306.98, -206.08, -200.68, -89.87, -93.67 ], "per_share_eps_estimate": [ -2.22, -2.27, -2.28, -1.49, -1.43, -0.59, -0.64 ], "eps_nri_estimate": [ -2.06, -2.12, -2.11, -1.38, -1.43, -0.59, -0.64 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -310.7, -317.54, -321.04, -244.7, -244.7, -244.7, -246.1 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }